| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $24,994,353 ) (Continued on the next page) |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R35NS097273 | Expanding insights into FTD disease mechanisms | 000 | 8 | NIH | 11/24/2023 | $985,949 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG071226 | Endothelial cell senescence and APOE4 in vascular cognitive impairment and dementia | 000 | 2 | NIH | 2/29/2024 | $352,125 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01DK139604 | Protein Kinase D1 as a switch from acute to chronic pancreatitis | 000 | 1 | NIH | 3/1/2024 | $340,388 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01DK139207 | Deciphering Pancreatitis Microenvironment through Intravital Imaging | 000 | 1 | NIH | 3/27/2024 | $578,659 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01EB035231 | Deep learning for opportunistic screening for osteoporosis and osteopenia from radiographs | 000 | 1 | NIH | 3/13/2024 | $304,632 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | F30AG085984 | The Role of TMEM106B in FTLD-TDP Pathogenesis | 000 | 1 | NIH | 12/6/2023 | $47,894 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG076537 | Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease | 000 | 2 | NIH | 2/9/2024 | $521,047 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | U19AG074879 | Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations | 000 | 2 | NIH | 4/15/2024 | $8,291,222 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG079859 | Therapeutic evaluation of targeting Tau Tubulin kinase-1 in Alzheimer?s disease | 000 | 2 | NIH | 1/31/2024 | $492,975 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG077771 | Nuclear import receptors as modifiers of TDP-43 phase transition and toxicity in FTD/ALS | 000 | 2 | NIH | 11/7/2023 | $624,382 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG071513 | Investigating tau and ApoE4-mediated alterations in oligodendrocyte progenitor cells | 000 | 3 | NIH | 3/8/2024 | $568,333 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01GM144393 | Exploiting new approaches for selective inhibition of trypsins | 000 | 3 | NIH | 11/8/2023 | $261,703 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG075802 | Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease | 000 | 3 | NIH | 11/7/2023 | $2,772,090 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA262393 | Targeted Prevention of Postpartum-Related Breast Cancer (PRBC) | 001 | 3 | NIH | 4/16/2024 | $32,495 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA262393 | Targeted Prevention of Postpartum-Related Breast Cancer (PRBC) | 000 | 3 | NIH | 2/23/2024 | $584,952 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01NS129671 | Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma | 001 | 2 | NIH | 4/16/2024 | $43,286 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01NS129671 | Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma | 000 | 2 | NIH | 12/8/2023 | $556,542 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA258274 | Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy | 001 | 4 | NIH | 4/18/2024 | $16,126 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA258274 | Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy | 000 | 4 | NIH | 2/12/2024 | $290,242 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R37CA248298 | Role of Sirt2 in T Cell Metabolism | 002 | 5 | NIH | 4/18/2024 | $17,901 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R37CA248298 | Role of Sirt2 in T Cell Metabolism | 001 | 5 | NIH | 2/15/2024 | $322,194 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG065219 | Impact of T cells on the CNS during aging and Alzheimer?s disease | 000 | 5 | NIH | 4/18/2024 | $485,150 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG063780 | Mechanistic insights into the link between the A152T risk variant and tauopathy | 000 | 5 | NIH | 4/18/2024 | $402,502 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | K01CA237875 | Integrated molecular epidemiologic analysis of the one-carbon metabolism pathway and risk of HCC | 000 | 5 | NIH | 3/18/2024 | $150,656 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG066395 | TREM2-mediated microglial dynamic function in Alzheimer disease | 000 | 5 | NIH | 12/14/2023 | $667,901 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG066429 | Targeting emerging P2RX7 signaling pathways in animal models of Alzheimer's disease | 000 | 5 | NIH | 3/22/2024 | $352,125 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01DK117910 | Mechanisms of Hereditary Pancreatitis | 001 | 5 | NIH | 2/8/2024 | $685,854 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01HL140411 | Distinct Pathways of VPF/VEGF Receptors | 000 | 5 | NIH | 3/13/2024 | $667,504 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R35NS097273 | Expanding insights into FTD disease mechanisms | 001 | 8 | NIH | 2/7/2024 | $0 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R21CA279916 | Deiminated molecules as markers for developing pancreatic cancer - A1 | 000 | 1 | NIH | 12/15/2023 | $182,909 |
| | 2024 | 2024 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | P01NS084974 | Pathobiology of Neurodegeneration in C9ORF72 repeat expansion | 000 | 10 | NIH | 4/11/2024 | $2,581,235 |
| | 2024 | 2023 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | UH2AG083186 | Mayo Advancing Research Equity in ADRD Study in Jacksonville(MAREAS-Jax) | 000 | 1 | NIH | 2/2/2024 | $0 |
| | 2024 | 2023 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | U01CA274970 | Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida | 001 | 3 | NIH | 1/31/2024 | $682,863 |
| | 2024 | 2023 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | U24CA277825 | The Data, Evaluation, and Coordination Center (DECC) for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) | 002 | 3 | NIH | 3/6/2024 | $543,317 |
| | 2024 | 2023 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG077656 | Accelerated Resolution Therapy for Early Maladaptive Grief: A Clinical Trial | 000 | 1 | NIH | 2/8/2024 | $0 |
| | 2024 | 2023 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R24AG074867 | Tailoring Recruitment Communication using Virtual Human Technology to Increase Participation of Older Minority Adults in Clinical Trials | 001 | 4 | NIH | 4/5/2024 | $561,112 |
| | 2024 | 2023 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R37CA248298 | Role of Sirt2 in T Cell Metabolism | 000 | 4 | NIH | 1/3/2024 | $0 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | F31NS120605 | Neural stem cells proteomic contribution to glioblastoma malignancy | 000 | 2 | NIH | 2/26/2024 | $0 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R21AI163302 | Vitamin D Binding Protein (DBP) in Innate Immune Cell Response in Viral Myocarditis | 001 | 2 | NIH | 10/11/2023 | -$18,925 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01CA257241 | Rational translation of gold nanoparticle mediated radiosensitization to the clinic | 000 | 2 | NIH | 11/16/2023 | -$572,638 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01DK117910 | Mechanisms of Hereditary Pancreatitis | 000 | 4 | NIH | 1/31/2024 | $0 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R01AG058812 | Role of CD38 in NAD metabolism: from the basic biology of aging to translation | 000 | 6 | NIH | 2/29/2024 | $0 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | K01HG009542 | Factors Influencing Access and Utilization of Genetic Prenatal Care Services Among Women from Underserved Populations | 003 | 6 | NIH | 1/23/2024 | -$471 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | K01HG009542 | Factors Influencing Access and Utilization of Genetic Prenatal Care Services Among Women from Underserved Populations | 002 | 6 | NIH | 1/23/2024 | -$997 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | K01HG009542 | Factors Influencing Access and Utilization of Genetic Prenatal Care Services Among Women from Underserved Populations | 001 | 6 | NIH | 10/30/2023 | $0 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | K01HG009542 | Factors Influencing Access and Utilization of Genetic Prenatal Care Services Among Women from Underserved Populations | 000 | 6 | NIH | 10/30/2023 | $0 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | R25CA214225 | Florida Cancer ReTOOL Program for Underrepresented Minority Students | 000 | 6 | NIH | 1/29/2024 | -$83,268 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | U01AG046139 | A Systems Approach to Targeting Innate Immunity in AD | 000 | 10 | NIH | 2/6/2024 | $0 |
| | 2024 | 2022 | MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | 4500 SAN PABLO RD S | JACKSONVILLE | FL | 32224-1865 | DUVAL | USA | U01AG046139 | A Systems Approach to Targeting Innate Immunity in AD | 000 | 10 | NIH | 2/6/2024 | $0 |
|
